Survey and Research Archives | Be Korea-savvy

Archive by category Survey and Research

Bitdeer AI Named Top 100 Software Companies of 2024 by The Software Report

Bitdeer AI Named Top 100 Software Companies of 2024 by The Software Report

SINGAPORE, Nov. 21, 2024 (Korea Bizwire) – Bitdeer AI, part of Bitdeer Technologies Group (NASDAQ: BTDR), an emerging AI cloud service provider, is proud to announce its inclusion in the Top 100 Software Companies of 2024, ranked 8 in the Cloud Management by The Software Report. The Software Report’s Top 100 Software Companies award is [...]

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

Recursion and Exscientia, two leaders in the AI drug discovery space, have officially combined to advance the industrialization of drug discovery

Recursion unveils post-combination technology-enabled portfolio with more than 10 clinical and preclinical programs, 10 advanced discovery programs, and more than 10 partnered programs Platform will focus on first and best-in-class drug discovery and development, demonstrating the ability to find novel insights and dramatically reduce the time and cost of discovery Recursion will host an update [...]

Colliers’ 2025 Global Investor Outlook Reveals Renewed Investor Optimism in Commercial Real Estate as Pricing Stabilizes

Colliers’ 2025 Global Investor Outlook Reveals Renewed Investor Optimism in Commercial Real Estate as Pricing Stabilizes

Broad momentum across asset classes, private wealth to reshape capital flows LONDON and TORONTO, Nov. 19 (Korea Bizwire) — Leading global diversified professional services company Colliers released its 2025 Global Investor Outlook, revealing renewed investor optimism and confidence that the commercial property market has moved past an inflection point following two years of muted transactions. On [...]

GBI Announces Class of 2024 Green Globes and Guiding Principles Compliance Fellows

GBI Announces Class of 2024 Green Globes and Guiding Principles Compliance Fellows

PORTLAND, Ore., Nov. 19, 2024 (Korea Bizwire) – The Green Building Initiative (GBI) celebrates the recognition of ten individuals with distinctions of Green Globes Fellow (GGF) and Guiding Principles Compliance Fellow (GPCF). GBI’s Fellow program, introduced in 2021, recognizes those who have demonstrated outstanding success in the improvement of the built environment through GBI’s Green Globes certification and/or Guiding Principles Compliance verification [...]

Boehringer’s focus on Health Equity drives significant upgrade in Access to Medicine Index Ranking

Boehringer’s focus on Health Equity drives significant upgrade in Access to Medicine Index Ranking

Boehringer Ingelheim, a leading research-driven biopharmaceutical company, has been lifted to 8th place in the 2024 Access to Medicine Index (ATMI), up from 13th in 2022. This improvement reflects the company’s strategic shift of prioritizing Health Equity as its primary contribution to the United Nations Sustainable Development Goals (UN SDGs).  Every two years the ATMI [...]

New Report Forecasts How to Navigate Global Student Mobility in 2025

New Report Forecasts How to Navigate Global Student Mobility in 2025

ApplyBoard’s fourth annual trends report reveals significant shifts in student destination preferences and the growing impact of AI on international education KITCHENER, Ontario, Canada, Nov. 19, 2024 (Korea Bizwire) – ApplyBoard, the leading international student mobility technology platform, today released its fourth annual trends report, examining the transformative changes reshaping international education. The report, “Navigating Global [...]

WiDEF announces first awardees of funding to close the gender digital divide

WiDEF announces first awardees of funding to close the gender digital divide

Ten trailblazing organizations from the Global South to receive over $14 million for digital inclusion efforts Washington, D.C., Nov. 18, 2024 (Korea Bizwire) – The Women in the Digital Economy Fund (WiDEF) is proud to announce the awardees of its first round of funding. Ten organizations, spanning eight countries across East Africa, West Africa, South [...]

Junshi Biosciences Announces UK MHRA Approval for Marketing of Toripalimab

Junshi Biosciences Announces UK MHRA Approval for Marketing of Toripalimab

SHANGHAI, Nov. 16, 2024 (Korea Bizwire) – Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, and its wholly-owned subsidiary, TopAlliance Biosciences Inc. (TopAlliance Biosciences), announced that the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved [...]

Curium Announces ECLIPSE Trial Has Met Primary Endpoint, Demonstrating a Statistically Significant and Clinically Meaningful Benefit for Patients With PSMA-Positive Metastatic Castration Resistant Prostate Cancer

Curium Announces ECLIPSE Trial Has Met Primary Endpoint, Demonstrating a Statistically Significant and Clinically Meaningful Benefit for Patients With PSMA-Positive Metastatic Castration Resistant Prostate Cancer

ST. LOUIS, Nov. 13, 2024 (Korea Bizwire) – Curium, a world leader in nuclear medicine, announced today that its ECLIPSE trial met its primary endpoint. ECLIPSE is a pivotal Phase 3, multi-center, open-label, randomized clinical trial comparing the safety and efficacy of 177Lu-PSMA-I&T (INN: lutetium (177Lu) zadavotide guraxetan) versus hormone therapy in patients with metastatic castration-resistant [...]

EAACI to Launch World Anaphylaxis Awareness Day on 21 November at FAAM-EUROBAT 2024

EAACI to Launch World Anaphylaxis Awareness Day on 21 November at FAAM-EUROBAT 2024

ATHENS, Greece, Nov. 13, 2024 (Korea Bizwire) – The European Academy of Allergy and Clinical Immunology (EAACI) is proud to announce the inaugural World Anaphylaxis Awareness Day on 21 November 2024. This landmark initiative, held on the opening day of FAAM-EUROBAT 2024 in Athens, Greece, seeks to raise awareness and promote essential steps in preventing and managing anaphylaxis, a severe, [...]